Enhanced detection of open-angle glaucoma

Article

Using an anatomically accurate OCT-derived neuroretinal rim parameter

An estimated 79.6 million people will have glaucoma by 2020,1 and the disease already accounts for over 10 million visits to physicians each year.2 Primary open-angle glaucoma is a slowly progressive disease characterized by degeneration of retinal ganglion cells with loss of the retinal nerve fibre layer (RNFL) and thinning of the neuroretinal rim of the optic nerve head. However, new information indicates that current rim measurements lack a solid anatomical foundation and may not accurately reflect rim width.

Current optic disc margin-based neuroretinal rim estimates assume that the clinically visible disc margin is the true anatomic border of the rim tissue from which width, area or volume measurements can be made. Professor Claude Burgoyne, myself, and colleagues3,4,5 recently co-localized stereo optic disc photographs to spectral-domain optical coherence tomography (SD-OCT) and found that:

1) the clinically identified disc margin is rarely a single anatomic entity or an identifiable anatomic junction;

3) rim width measurements made in the plane of the perceived disc margin are inaccurate compared to those that take into account the orientation of the overlying rim tissue.

The scientists developed a new, objective method for measuring the rim that uses the Bruch's Membrane opening (BMO), a logical anatomical outer border of the rim. With the Spectralis SD-OCT (Heidelberg Engineering GmbH, Heidelberg, Germany), a measurement is made from the BMO to the nearest point on the internal limiting membrane (ILM) quantifying the cross section of the nerve fibres exiting the eye also referred to as BMO-based minimum rim width (BMO-MRW).

Other studies by the same group found that BMO-MRW measurements deviated regionally and significantly from conventional rim margin measurement.4 The BMO-MRW measurements are more accurate because they are based on an identifiable border of the rim and take into account its varying trajectory relative to the point of measurement. The investigators also demonstrated that use of the BMO-MRW measurement translates into significantly enhanced diagnostic precision compared to the currently used cSLO or SD OCT-based optic nerve head and RNFL thickness parameters. At 95% specificity, the sensitivity of RNFLT measurements ranged from 31% to 59%, compared to the BMO-MRW measurement, whose sensitivity ranged from 54% to 79%, a significant improvement.

Heidelberg Engineering is currently working with the investigators to develop software for the Spectralis that will employ this new neuroretinal rim analysis.

References

1. H.A. Quigley and A.T. Broman, Br. J. Ophthalmol., 2006;90(3):262–267.

2. Center for Disease Control and Prevention/National Center for Health Statistics, 2010 & 1995. Viewed April 20, 2013 at http://www.cdc.gov/nchs/data/hus/hus10.pdf

3. B.C. Chauhan et al., Ophthalmology, 2013;120:535–543.

4. A.S. Reis et al., Invest. Ophthalmol. Vis. Sci., 2012;53:1852–1860.

5. A.S. Reis et al., Ophthalmology, 2012;119:738–747.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
Related Content
© 2025 MJH Life Sciences

All rights reserved.